Clinical Trial Update: A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease [NA]

View source ↗

Summary

Phase 2 trial evaluating rituximab plus corticosteroid therapy as initial treatment for newly diagnosed chronic graft-versus-host disease; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Corticosteroids (corticosteroids)
• Rituximab (rituximab)

Snippet

Sponsor: Stanford University | Conditions: Graft vs Host Disease | NA | Status: COMPLETED | Results posted: 2017-11-20